Markus M.
- Country
- Germany
- Department
- Department of Paediatric Oncology, and Haematology
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Revumenib in Combination with Fludarabine and Cytarabine for Pediatric Refractory or Relapsed KMT2A-r, NUP98-r, or NPM1-mut Acute Myeloid Leukemia
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
Data & Insights
Has run more than one trial at 252 of 358 partner sites.
Specializations
Pediatric Hematologic Malignancies
Specializes in treating various forms of acute lymphoblastic leukemia and chronic myeloid leukemia, with particular emphasis on novel therapeutic approaches for pediatric and adolescent patients.
- Philadelphia chromosome-positive leukemias
- Infant ALL treatment protocols
- Relapsed/refractory leukemia management
Pediatric Solid Tumors
Focuses on advancing treatment options for children with Ewing sarcoma, rhabdomyosarcoma, and neuroblastoma, incorporating targeted therapies and immunological approaches.
- GD2-positive tumor treatments
- Risk-adapted therapy strategies
- Novel combination treatments
Neuro-oncology
Dedicated to treating pediatric brain tumors including medulloblastoma, ependymoma, and low-grade gliomas, with expertise in molecular-based treatment approaches.
- Targeted RAF pathway inhibition
- Risk-stratified radiation protocols
- Integrated treatment strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.